Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05321147 |
|---|---|
| Brief Title: | Safety and Efficacy of Lacutamab in Patients With Relapse Peripheral T-cell Lymphoma That Express KIR3DL2 |
| First Submitted : | April 4, 2022 |
| First Submitted that Met QC Criteria : | April 4, 2022 |
| First Posted : | April 11, 2022 |
| Last Update Submitted that Met QC Criteria : | April 4, 2022 |
| Last Update Posted : | April 11, 2022 |